Michael Giberson is an associate professor of practice in the Jerry S. Rawls College of Business at Texas Tech University. He is an expert in the areas of energy economics, U.S. energy policy and the electric power industry. Giberson's research and writing focuses on U.S. energy policy and electric power markets, and on the law and economics of price gouging. He is a faculty affiliate at the Free Market Institute at Texas Tech University. Prior to joining Texas Tech in 2008 he worked with Potomac Economics, Ltd., an economic consulting firm specializing in the electric power industry. Michael Giberson has been published in Nature Energy, the Electricity Journal, the Journal of Regulatory Economics, the Pacific and Asian Journal of Energy, and Regulation magazine, and has written on U.S. energy policies and federal electric power issues for trade publications. He is co-author with Lynne Kiesling of the Knowledge Problem blog discussing economics, energy policy, technology and many other topics. Energy posts at Knowledge Problem are included at Social Media Today's The Energy Collective online community. In addition, his commentary and analysis has appeared at Alternative Energy Stocks and MasterResource. Giberson earned his bachelor's degree in economics from Texas Tech and his master's and doctorate degrees in economics from George Mason University.
Michelle Litchman, PhD, APRN, FNP-BC, is an assistant professor at the College of Nursing and School of Medicine at University of Utah Health. She is a researcher and diabetes nurse practitioner who studies ways to improve outcomes for patients with type I diabetes. In particular, she is studying the effect of apomediation, where peers guide a participant to correct information. Online communities offer low cost support that is available all the time. Her work examines if diabetes patients experience health benefits from social media-based peer health groups.
Michelle Litchman, PhD, FNP-BC, FAANP is an Assistant Professor at the College of Nursing and School of Medicine. Her position includes research, teaching, and clinical work at the Utah Diabetes and Endocrinology Center. She is passionate about teaching and precepts health sciences students and teaches didactic courses at the College of Nursing. Dr. Litchman’s program of research emphasizes the social context of chronic disease management across the lifespan with a particular emphasis on diabetes and technology. Her research examines online environments to understand the influence of peer support on health outcomes and diabetes management in the “real-world”. Dr. Litchman also examines family dynamics to understand how diabetes management is supported or derailed, and how technology might be helpful.
Sickle Cell Disease, Hemophilia, Blood Cancer, Blood Disease
Modupe Idowu, MD, treats patients with sickle cell anemia, myeloproliferative neoplasm, thrombotic disorders, and hematologic malignancy including lymphoproliferative disorders, plasma cell dyscracias, and leukemias. Her research interests in clinical and translational investigations involve sickle cell anemia and thrombotic disorders. She is the medical director of the UT Physicians Comprehensive Sickle Cell Center.
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System Cancer Care. He joined Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise. With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health. Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium. As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally. Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits.
I run the Positive Emotion and Social Behavior Lab. We examine how specific emotions influence relationship building and personal well-being outcomes. Much of my work has focused on the emotion gratitude and its role in shaping our relationships with others, both through our personal experience of gratitude and in our expression of gratitude to others.
Paleoclimate expert Morgan Schaller, an assistant professor of earth and environmental sciences at Rensselaer Polytechnic Institute, studies the history of the Earth system and changes in the climate over long timescales. In recent research published in Science, Schaller identified an extraterrestrial impact as the likely trigger for the Paleocene-Eocene Thermal Maximum (PETM), a rapid warming of the Earth caused by an accumulation of atmospheric carbon dioxide 56 million years ago. The PETM is considered an analog to global warming today.
Morhaf Al Achkar is a 36-year-old family medicine physician at UW Medicine who has been living with stage 4 lung cancer for more than three years. Dr. Al Achkar never smoked but, like many with the disease, he has a genetic type of lung cancer. After a year of living with the disease, Al Achkar reached out to other people living with stage 4 lung cancer for inspiration. He gathered 40 stories of inspiration that were recently published in the book, “Roads to Meaning and Resilience with Cancer.” Lung cancer is the leading cause of cancer deaths. In 2019, alone, it is expected that 228,150 people will be diagnosed with lung cancer, and more than 142,670 will die from it, according to the American Cancer Society. While a significant proportion of patients with lung cancer are diagnosed at advanced stages and have a survival rate of a few months, there are glimmers of hope. Al Achkar has a type of lung cancer has responded to treatment with targeted therapy in the form of pills he takes everyday. As a qualitative researcher, Al Achkar knew stage 4 lung cancer was a novel area of research. He said the need for such work is enormous as the experience of people with advanced lung cancer has been associated with stigma and blame. He wanted to break that cycle and help anyone dealing with a serious illness as well as inspire those he describes “with the gift of health.”
Neal A. Lester is an expert in African American literary, cultural studies, racial bias and discrimination, especially as regards African Americans. Lester is a Foundation Professor of English at ASU where he is founding director of the award-winning Project Humanities initiative. He’s also a popular public speaker, radio guest, op-ed contributor, newspaper columnist, blogger, and discussion facilitator. He is the author, co-author or editor of seven books and numerous articles in journal and magazines on topics such as children's literature, drama, folklore, the politics of hair, the "n-word," and racialized images in American cinema. The recipient of dozens of honors and awards for public scholarship and professional service, Lester conducts race and privilege training in the community and leads Project Humanities' Service Saturdays, an outreach to those experiencing homelessness, once per month in downtown Phoenix.
Neil B. Friedman, M.D., FACS, is Director of The Hoffberger Breast Center at Mercy as well as Medical Director of The Weinberg Center for Women's Health and Medicine at Mercy. As a catalyst for advancing breast cancer treatment, Dr. Friedman has partnered with many prestigious national and local organizations to improve the treatment options for women with breast cancer. Likewise, on a very personal level, he partners with each of his patients and their families to help them face the challenges and triumphs of living with a breast cancer diagnosis. Dr. Friedman led the charge to bring IORT, Intraoperative Radiotherapy, to Mercy making it the first hospital in Maryland to offer this leading-edge technology. Dr. Friedmane began his medical career as Chief Resident at the nationally renowned Memorial Sloan-Kettering Cancer Center in New York. He is a Board Certified breast cancer doctor who is dedicated to the search for a cure for cancer. His team continues to lead breast cancer initiatives and introduce best-in-practice breast care treatment options, including Intraoperative Radiotherapy (IORT), an innovative, single-dose radiation treatment, to patients. Dr. Friedman was named Humanitarian of the Year by the Mildred Mindell Cancer Foundation for his efforts in the fight against breast cancer. He has served as a national spokesperson for breast cancer prevention for major organizations such as Bath & Bodyworks. Dr. Friedman has been the Chairman of the American Cancer Society’s Research Administrative Committee, a member of its Executive and Professional Education Committees, and served on its Board of Directors. He has also been involved with the Susan G. Komen Breast Cancer Foundation. Dr. Friedman leads a team of clinicians devoted to breast cancer education, advocating the latest advancements in diagnosis and treatment of breast cancer at a number of conferences, continuing education forums, and patient seminars. Dr. Neil Friedman remains committed in his career to find optimal treatments for breast cancer. Some of his accomplishments include: • Named a “Top Doc” by Baltimore magazine in the Breast Surgery category • Named Humanitarian of the Year by the Mildred Mindell Cancer Foundation • The Breast Center at Mercy Medical Center first in Maryland to offer IORT Treatment • Research on cancer has been published in American Journal of Public Health(APHA) and the Journal of Immunotherapy
Dr. Reksten joined the economics department at the University of Redlands in 2016 after teaching at Sarah Lawrence College and American University. His expertise ranges from basic economics to the economic impact of environmental issues. He is an award-winning educator and researcher with a unique focus on economics and the environment.
Executive director of the O’Neill Institute for National and Global Health Law and a visiting professor of Law at Georgetown Law. He is a co-director of the World Health Organization Collaborating Center on National and Global Health Law. Cabrera has worked on projects with the World Health Organization, the Centers for Disease Control and Prevention, and the Campaign for Tobacco Free Kids, among other organizations. He has studied and is interested in various health law-related fields, such as public health law, sexual and reproductive rights, health and human rights, global tobacco litigation and health systems law and policy. Cabrera can comment in English or Spanish on the actions of the WHO and International Health Regulations related to Ebola.
Dr. Vijayanand was appointed an Associate Professor in the Division of Vaccine Discovery in 2015. He is the inaugural holder of the William K. Bowes Distinguished Professorship Dr. Vijayanand received his M.D. from the MGR Medical University in Chennai, India, and completed his residency in Internal Medicine followed by a Pulmonary Fellowship in the United Kingdom. In 2008, he obtained his Ph.D. from the University of Southampton, United Kingdom, where he studied the mechanisms of accumulation and activation of T cells in human asthma. Since then, Dr. Vijayanand has split his time between laboratory research and seeing patients at the University of Southampton, where he currently holds an appointment as an Associate Professor in the School of Medicine. In 2007, he was awarded a prestigious National Career Development Fellowship to undertake translational studies in the epigenetic regulation of the immune cell signaling molecules in human asthma at UC San Francisco, where he was appointed adjunct assistant professor in the Department of Medicine in 2009. Two years later, Vijay joined the La Jolla Institute for Allergy and Immunology as an adjunct assistant professor in the Division of Signaling and Gene Expression.
Patricia E. Molina, MD, PhD, is the Richard Ashman Professor and Head of Physiology, and Director of the Alcohol and Drug Abuse Center at LSU Health Sciences Center New Orleans’ School of Medicine. Dr. Molina's training as a physician prior to completing training in physiology provides her with a unique systems approach to study the biomedical consequences of chronic heavy alcohol use, with emphasis on the pathophysiological mechanisms that aggravate HIV disease progression. Her research focuses on the interaction of chronic alcohol consumption on progression of HIV disease in preclinical models and in translational studies. Her research involves integrating in vivo with ex vivo approaches to understand the contribution of organ systems to disease pathogenesis. Another area of research interest and ongoing investigations is the interaction of alcohol with outcomes from traumatic brain injury. Her work examines the mechanisms that lead to greater alcohol drinking during the post-injury phase, and the potential role of the endocannabinoid system in modulating those responses. Dr. Molina is interested in translating research findings to the community at large, and in educating the lay public on the consequences of excessive alcohol consumption. This is particularly relevant to young students and parents as they make decisions on alcohol drinking throughout their life.
Astrophysicist Patrick Brady at the University of Wisconsin-Milwaukee yesterday began his duties as spokesperson for the international scientific collaboration that studies gravitational waves using the Laser Interferometer Gravitational-Wave Observatory (LIGO). The spokesperson of the LIGO Scientific Collaboration (LSC) speaks on behalf of the 1,300 scientists in 20 countries who are engaged in gravitational wave research with data from observatories located in Hanford, Washington, and Livingston, Louisiana. Brady, a UWM professor of physics and director of the Leonard E. Parker Center for Gravitation, Cosmology and Astrophysics, is sixth in an elite group of scientists who have served as LSC spokespersons since the LSC formed in the late 1990s. Former spokespersons were Nobel Prize winner Rainer Weiss (Massachusetts Institute of Technology), Peter Saulson (Syracuse University), Dave Reitze (Caltech), Gabriela Gonzalez (Louisiana State University) and David Shoemaker (MIT). Brady’s research focuses on the analysis and interpretation of data from the network of gravitational-wave detectors. He served on the executive committee of the LSC from 2004-2006, and has co-chaired the LSC Inspiral Analysis Group and chaired the LSC Data Analysis Software Working Group. He joined the UW-Milwaukee faculty in 1999, after a fellowship at Caltech. In 2010 he was elected a Fellow of the American Physical Society, and he shared in the 2016 Special Breakthrough Prize. Video from 2017: https://www.pbs.org/video/measuring-gravity-waves-with-ligo-vkft6w/
Paul R. Lucas, M.D., is an experienced vascular surgeon and Director of The Vascular Center at Mercy in Baltimore, Maryland. He is Board Certified in Vascular Surgery and has been recognized as a Top Doc by Baltimore magazine numerous times. Dr. Lucas leads a team of vascular surgeons and technologists who specialize in the diagnosis and treatment of patients with diseased blood vessels. His patients admire his attentive and caring professionalism and he is noted for taking the time to be sure they understand their condition and treatment options. Dr. Paul Lucas utilizes the latest technologies to care for patients experiencing vascular disorders. He specializes in Venefit™ (formerly known as VNUS Closure™) and Veingogh© procedures for varicose vein removal and is continuously seeking advanced diagnostic and treatment options for more efficient care. Dr. Paul Lucas is a Registered Physician in Vascular Interpretation and was instrumental in the establishment of Mercy's nationally accredited Vascular Laboratory at The Vascular Center at Mercy. Patients can be screened at all of Mercy’s physician office locations throughout Greater Baltimore, making diagnosis and subsequent scheduling for treatment convenient. Using non-invasive Doppler ultrasound equipment, lab technologists screen patients for circulatory problems like mini-strokes, circulation issues, leg swelling or pain, blood clots and aneurysms.
Paul J. Ferraro, PhD, is the Bloomberg Distinguished Professor of Business and Engineering at Johns Hopkins University. Dr. Ferraro has a joint faculty appointment in the Whiting School of Engineering and the Carey Business School. His research focuses on behavioral economics and the design and evaluation of environmental programs in the private and public sectors. Because these research areas are multi-disciplinary and applied, he collaborates with scientists and engineers from a variety of social, natural and physical science disciplines, as well as practitioners in the field.